## **Core Concept**
Hypertensive uveitis refers to a condition where there is inflammation of the uvea (uveitis) accompanied by elevated intraocular pressure (IOP). Management of this condition requires careful consideration of both the inflammation and the elevated IOP. The drug of choice should ideally address both aspects.

## **Why the Correct Answer is Right**
The correct answer, **Betaxolol**, is a beta-blocker that is used topically in the eye to decrease intraocular pressure (IOP) by reducing aqueous humor production. Unlike non-selective beta-blockers, betaxolol is a selective β1-adrenergic receptor blocker, which may have a theoretical advantage in certain cases due to its lower propensity to cause bronchospasm. However, in the context of hypertensive uveitis, the key consideration is its IOP-lowering effect without significant impact on the uveitis itself; anti-inflammatory drugs would be used concurrently for the uveitis.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and thus cannot be evaluated.
- **Option B:** This option is blank and thus cannot be evaluated.
- **Option D:** This option is blank and thus cannot be evaluated.

## **Clinical Pearl / High-Yield Fact**
In managing hypertensive uveitis, it's crucial to control both the inflammation (with anti-inflammatory agents like corticosteroids) and the elevated IOP. Beta-blockers like **betaxolol** are useful for lowering IOP. Always consider the potential side effects and interactions of these medications, especially in patients with systemic conditions.

## **Correct Answer:** . **Betaxolol**